PMVP
Pmv Pharmaceuticals Inc
1.80$
-0.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -10.1% | +477.5% | -0.7% | -59.0% | +7.2% | -19.6% | +11.1% | -48.8% | +350.0% | -3.0% | +0.3% | +0.8% | +2.8% | – | – | – | – | +0.0% | +3.1% | +3.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -3.7% | +16.4% | +4.5% | -2.5% | +3.2% | +3.2% | +21.3% | +2.2% | +19.5% | +32.8% | -2.7% | -3.2% | +19.2% | +9.9% | +0.3% | -8.2% | -1.9% | -4.1% | -1.5% | +11.2% | +18.9% | -18.8% | +26.7% | +5.3% | -0.9% | -13.1% | -3.4% | -4.1% | – | |
| – | +0.0% | +15.5% | +7.2% | +2.6% | +34.3% | +18.8% | +59.5% | -3.4% | +29.0% | +10.2% | +6.2% | +7.6% | -5.3% | -11.1% | +7.5% | +4.4% | -2.0% | -3.8% | -8.6% | -8.8% | +10.1% | -10.8% | +130.7% | -63.8% | +8.6% | -3.7% | -20.8% | +8.0% | +14.0% | – | |
| – | +0.0% | +0.4% | +14.2% | +4.1% | +5.6% | +7.6% | +20.7% | +11.2% | +11.8% | +15.7% | +22.4% | +0.8% | -3.9% | +8.3% | +9.2% | +1.5% | -6.3% | -2.5% | -5.5% | -3.7% | +10.9% | +10.6% | +15.0% | -14.3% | +5.9% | -1.4% | -14.6% | -1.3% | -0.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +163.8% | +88.2% | -26.7% | +182.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +600.0% | – | – | -7,950.0% | – | -66.7% | +300.0% | -2,925.0% | – | +21.1% | -91.3% | -200.0% | – | – | – | – | -9,050.0% | – | – | -5,174.3% | – | – | – | – | -220.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.